Capital36 FIZ has acquired The Kusnacht Practice AG
Capital36 FIZ has acquired The Kusnacht Practice AG for an undisclosed consideration.
Capital36 FIT is a Poland-based investment fund that invests primarily in the medical sector.
The Kusnacht Practice AG treats alcoholism and drug addiction, eating disorders, gambling compulsivity, sex and love, as well as internet compulsion. The clinic’s approach involves one client working one-on-one with therapists eight hours a day. An international team of doctors, therapists, nurses, counsellors and other professionals offers a full range of addiction treatment and psychiatric services for individuals and their families. The clinic, founded in 2011, operates in the high-end sector and patients are mainly HNWIs and their relatives from all over the world.
Oaklins' team in Switzerland conducted the financial due diligence on behalf of the buyer, providing a comprehensive financial model and business planning support and assisting them in the closing process.
Talk to the deal team
Related deals
Hemink Groep has been acquired by Gimv
Gimv has acquired a majority stake in Hemink, a Dutch specialist in real estate renovation and maintenance. This transaction marks a new chapter for Hemink, as it seeks to expand its position as a national leader in sustainable property services through its new partnership with Gimv.
Learn moreOGD has been sold to Building Beyond Technology Group
Building Beyond Technology Group (BBTG) strengthens its position in the IT sector by welcoming OGD IT-Dienstverlening (OGD) to its platform. With over 1,400 employees, OGD is an established name in the Dutch market as a mission-critical IT service provider for large-scale clients. This addition not only increases BBTG’s scale but also enhances its domain expertise and execution capabilities through close cooperation with the other platform companies.
Learn moreThe Providence Projects has been acquired by UKAT Group
Celebrity-success rehabilitation center, The Providence Projects, has joined The UK Addiction Treatment (UKAT) Group, backed by Sullivan Street Equity Partners.
Learn more